Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study

Background. Metabolic syndrome has been linked to an increased cancer risk, but the role of dyslipidaemia in gastrointestinal malignancies is unclear. We aimed to assess the risk of oesophageal, stomach, colon, and rectal cancers using serum levels of lipid components. Methods. From the Swedish Apol...

Descripción completa

Detalles Bibliográficos
Autores principales: Wulaningsih, Wahyu, Garmo, Hans, Holmberg, Lars, Hammar, Niklas, Jungner, Ingmar, Walldius, Göran, Van Hemelrijck, Mieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437288/
https://www.ncbi.nlm.nih.gov/pubmed/22969802
http://dx.doi.org/10.1155/2012/792034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437288/
https://www.ncbi.nlm.nih.gov/pubmed/22969802
http://dx.doi.org/10.1155/2012/792034

Ejemplares similares